Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RATgbuOZLLs8jbwErkw7wB5zUGOepyEm_XfGjyebQoCqs#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _5 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _5 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _4 provenance.
- assertion hadPrimarySource 16120828 provenance.
- _4 wasQuotedFrom 16120828 provenance.
- _4 value "EGF stimulates the phosphorylation (activation) of the signaling intermediate p38 (MAPK11/14), and blocking phosphorylation pharmacologically with either SB203580 or SB202190 strongly inhibited spontaneous and EGF-stimulated secretion of CGB. --From Materials and Methods: Primary antibodies to cyclin D1/CCND1and p21/CDKN1A (catalog numbers 2926 and 2946; mouse monoclonal) and phosphorylated (p)-MAPK11/14 (catalog number 9211; rabbit polyclonal) were obtained from Cell Signaling Technology (Beverley, MA) and used at a dilution of 1:500. -- From Cell Signaling Technologies: Phospho-p38 MAP Kinase (Thr180/Tyr182) Antibody detects endogenous levels of p38 MAP kinase only when activated by phosphorylation at threonine 180 and tyrosine 182." provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.